A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
Revised National TB Control Programme. Annual Status Report
This World Health Organization (WHO) and the International Labour Organization (ILO) joint guidelines production aims at harnessing the contribution of employers and workers towards the control of TB. It covers all the practical steps involved in es
...
tablishing TB control activities, including (for large employers) starting and running a workplace TB control programme. They are intended for use in all countries in which TB incidence is high and the target audience for the guidelines includes employers, employee organizations, NTP managers, and agencies providing technical support for TB control.
more
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of
...
key DR-TB drugs, using manufacturer responses to standardised questionnaires and the Global TB Drug Facility website.
more
treat TB
Description of Research Outputs, 2009 - 2014
The TB section of the toolkit presents selected (a) programmatic output and (b) outcome and impact indicators for TB. In addition to recommended monitoring programs and measuring the outcomes and im
...
pact of TB programs, indicators for the strengthening of health systems, strengthening of community systems and some indicators that measure quality of services are also included.
more
Lessons from the STEP-TB Project.
Accessed November 2017.
Copenhagen, Denmark, 7–8 March 2017. Meeting report
ERJ Open Res 2017; 3: 00002-2017
Reach the Unreached - FIND, TREAT, CURE TB, SAVE LIVES
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access
...
TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided in these settings is often not known or substandard. Closing these gaps and ensuring patient-centred care imply that quality-assured and affordable TB services must be made available wherever people choose to seek care.
more